The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...
Eli Lilly's fundamentals matter more than Trump's stock purchases.
Curevo Vaccine (Curevo), a clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability, today announced entry into a definitive ...
Shares of Eli Lilly rose 0.9% shortly after the market opened. "These acquisitions reflect a deliberate strategy to prevent ...
Novo Nordisk (NVO +0.89%) pioneered weight loss medicines with Wegovy, an anti-obesity therapy that quickly became a hit.
Eli Lilly is laying the groundwork for a phase 2 trial of the lipid-lowering gene editor it acquired from Verve Therapeutics, with the candidate now showing strong and consistent cholesterol ...
Eli Lilly has gone to federal court, accusing a web of pharmacies, wholesalers, and church-linked groups of orchestrating a ...
Eli Lilly & Co. is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results